Jan 5, 2022By: Rounak Jain
The Delhi High Court junked Future group’s plea to end arbitration with Amazon.
Distributors’ association has called off the boycott of HUL after the company assured of corrective action if needed.
Withdrew its new corporate structure changes announced in April 2021, stating that the existing structure is optimal enough to leverage emerging opportunities.
To launch COVID-19 drug molnupiravir under the brand name of Molflu, at ₹35 a capsule.
To invest $20 million in merchant point-of-sales solutions provider Pine Labs.
Its subsidiary approved the merger with a new vaccine subsidiary of Serum Institute of India, Covishield Technologies Pvt. Ltd.
Deposits grew 3 percent over the previous quarter, while advances rose 9 percent.
Acquired a 26 percent stake in ONGC Tripura Power Company.
Media reports suggest that the privatisation of the company might be pushed to next financial year due to a lack of adequate progress.